Clinical and Multiomics Study of First-line Chemotherapy for Advanced Pancreatic Cancer
NCT05168254
·
clinicaltrials.gov ↗
UNKNOWN
Status
50
Enrollment
OTHER
Sponsor class
Conditions
Pancreatic Ductal Adenocarcinoma, PDAC
Sponsor
Ruijin Hospital